Prateek Jain
Overview
Explore the profile of Prateek Jain including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
161
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Singh G, Trehan S, Singh A, Sandhu K, Ratnani P, Jain P, et al.
Cureus
. 2024 Nov;
16(10):e72474.
PMID: 39600743
Prostate cancer rates and outcomes show significant differences between African American (AA) and Caucasian men, with AA males experiencing higher incidence and mortality rates. These disparities result from a complex...
3.
Farooq A, Trehan S, Singh G, Arora N, Mehta T, Jain P, et al.
Cureus
. 2024 Oct;
16(9):e68748.
PMID: 39371877
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that causes extensive inflammation and tissue destruction across several organs. Conventional therapies, such as nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and immunosuppressive...
4.
Bector G, Trehan S, Jain P, Toofantabrizi M, Kaur M
Cureus
. 2024 Oct;
16(9):e68661.
PMID: 39371806
Solitary fibrous tumors (SFTs) of the central nervous system (CNS) are rare mesenchymal neoplasms with diverse histological characteristics ranging from benign to malignant. Their higher chance for metastasis and recurrence...
5.
Bector G, Trehan S, Toofantabrizi M, Singh G, Jain A, Arora N, et al.
Cureus
. 2024 Oct;
16(9):e68542.
PMID: 39364500
Immune checkpoint inhibitors (ICIs), including Imfinzi (durvalumab), have revolutionized cancer treatment by stimulating the body's immune system to target cancerous cells. Although pharmaceuticals offer therapeutic benefits, several drugs have been...
6.
Trehan S, Singh G, Bector G, Jain P, Mehta T, Goswami K, et al.
Cureus
. 2024 Sep;
16(8):e67010.
PMID: 39280497
Cardiovascular diseases (CVDs) are a leading cause of mortality worldwide. Recent research has identified gut dysbiosis - an imbalance in the gut microbiota - as a significant factor in the...
7.
8.
9.
Mehta T, Jain P, Pathania M, Ahuja N, Bhatia M
J Assoc Physicians India
. 2024 Jun;
72(6):109-110.
PMID: 38881149
No abstract available.
10.